Peptides as carrier for tumor diagnosis and treatment.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Current Medicinal Chemistry - Anti-Cancer Agents

• Publication date

  2001-05-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.3929/ETHZ-A-004120534PMID 12678771
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• 99mTc‐HYNIC PEGylated Peptide Probe Targeting HER2‐Expression in Breast Cancer

  2025cites this paper
• 68Ga-Labeled TMTP1 Modified with d-Amino Acid for Positron Emission Tomography Diagnosis of Highly Metastatic Hepatocellular Carcinoma.

  2024cites this paper
• Influence of PEGylation on HER2-targeting retro A9 peptide analogue.

  2024cites this paper
• 177Lu-labeling of nuclear localization sequence (NLS)-grafted HER2-receptor affine peptide.

  2024cites this paper
• Targeting HER2-receptors with 177Lu-labeled triazole stapled cyclic peptidomimetic.

  2023cites this paper
• Design, synthesis and evaluation of 177Lu-labeled inverso and retro-inverso A9 peptide variants targeting HER2-overexpression.

  2023cites this paper
• Synthesis and 177Lu Labeling of the First Retro Analog of the HER2-Targeting A9 Peptide: A Superior Variant.

  2023cites this paper
• Synthesis and comparative evaluation of 177Lu-labeled PEG and non-PEG variant peptides as HER2-targeting probes

  2022cites this paper
• A concise review on the role of natural and synthetically derived peptides involved in colorectal cancer.

  2022cites this paper
• Radiopharmaceutical Precursors for Theranostics

  2021cites this paper
• Peptide-functionalized liposomes as therapeutic and diagnostic tools for cancer treatment.

  2020cites this paper
• Strategies for Improving Stability and Pharmacokinetic Characteristics of Radiolabeled Peptides for Imaging and Therapy.

  2020cites this paper
• Radiolabeled peptide probes for liver cancer imaging.

  2020cites this paper
• Methods to Enhance the Metabolic Stability of Peptide-Based PET Radiopharmaceuticals

  2020cites this paper
• Study the 99m Tc-labeling conditions of HYNIC-conjugated peptides from a new perspective: Introduction to the term radio-stoichiometry.

  2020cites this paper
• The synthesis and analysis of a bombesin analogue for radiotherapy of prostate cancer

  2019cites this paper
• Targeting phosphatidylserine for radionuclide-based molecular imaging of apoptosis

  2019cites this paper
• Radiolabeled Bombesin Analogs to Improve Prostate Cancer Diagnosis by PET Imaging

  2019cites this paper
• Real-Time Label-Free Targeting Assessment and in Vitro Characterization of Curcumin-Loaded Poly-lactic-co-glycolic Acid Nanoparticles for Oral Colon Targeting

  2019cites this paper
• Synthetic peptide-labelled micelles for active targeting of cells overexpressing EGF receptors

  2019cites this paper
• Synthetic Peptide Libraries. From random mixtures to in vivo testing.

  2018cites this paper
• Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [64Cu]-DOTHA2-PEG-RM26.

  2018cites this paper
• Synthesis of podophyllotoxin linked β-carboline congeners as potential anticancer agents and DNA topoisomerase II inhibitors.

  2018cites this paper
• Tricine co-ligand improved the efficacy of 99mTc-HYNIC-(Ser)3-J18 peptide for targeting and imaging of non-small-cell lung cancer.

  2018cites this paper
• Radiolabelled peptides in medical imaging

  2018cites this paper
• Tumor targeting with 99mTc radiolabeled peptides: Clinical application and recent development

  2018cites this paper
• Cyclic-RGD penta-peptides cRGDyK derivatized with cyclopentadienyl complexes of technetium and rhenium as radiopharmaceutical probes.

  2017cites this paper
• Preparation and biological evaluation of 99mTc-HYNIC-(Ser)3-D4 peptide for targeting and imaging of non-small-cell lung cancer.

  2017cites this paper
• Tumor detection using magnetosome nanoparticles functionalized with a newly screened EGFR/HER2 targeting peptide.

  2017cites this paper
• Recent developments in anticancer drug delivery using cell penetrating and tumor targeting peptides

  2017cites this paper
• Targeting Phosphatidylserine with a 64Cu-Labeled Peptide for Molecular Imaging of Apoptosis.

  2016cites this paper
• Design of smart GE11-PLGA/PEG-PLGA blend nanoparticulate platforms for parenteral administration of hydrophilic macromolecular drugs: synthesis, preparation and in vitro/ex vivo characterization.

  2016cites this paper
• Optimization and in Vivo Validation of Peptide Vectors Targeting the LDL Receptor.

  2016cites this paper
• Synthesis and in vitro and in vivo evaluation of an (18)F-labeled neuropeptide Y analogue for imaging of breast cancer by PET.

  2015cites this paper
• Bombesin Encapsulated in Long-Circulating pH-Sensitive Liposomes as a Radiotracer for Breast Tumor Identification.

  2015cites this paper
• Novel radiolabeled peptides to improve breast and prostate cancer diagnosis by PET

  2015cites this paper
• A cleavable cytolysin-neuropeptide Y bioconjugate enables specific drug delivery and demonstrates intracellular mode of action.

  2015cites this paper
• Targeted therapy of colorectal neoplasia with rapamycin in peptide-labeled pegylated octadecyl lithocholate micelles.

  2015cites this paper
• Radiolabeled FMLF a Valuable Peptide for Diagnostic Imaging

  2014cites this paper
• Synthesis of tripeptide derivatized cyclopentadienyl complexes of technetium and rhenium as radiopharmaceutical probes.

  2014cites this paper
• Screening and selection of peptides specific for esophageal cancer cells from a phage display peptide library

  2014cites this paper
• Peptide labelling strategies for imaging agents.

  2014cites this paper
• Metallo-Biopolymers: Conjugation Strategies and Applications

  2014cites this paper
• In vivo studies: comparing the administration via and the impact on the biodistribution of radiopharmaceuticals.

  2014cites this paper
• Stapling of the botulinum type A protease to growth factors and neuropeptides allows selective targeting of neuroendocrine cells

  2013cites this paper
• In vitro evaluation of 99mTc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines

  2013cites this paper
• Tumour targeting with radiometals for diagnosis and therapy.

  2013cites this paper
• Xentry, a new class of cell-penetrating peptide uniquely equipped for delivery of drugs

  2013cites this paper
• Peptides for Nuclear Medicine Therapy: Chemical Properties and Production

  2013cites this paper
• Low density lipoproteins mediated nanoplatforms for cancer targeting

  2013cites this paper
• 99mTc-labeled bombesin analog for breast cancer identification

  2013cites this paper
• Tumor Targeting With a TcMAG-3 Labeled Molecular Engine by

  2012cites this paper
• Bifunctional chelators in the design and application of radiopharmaceuticals for oncological diseases.

  2012cites this paper
• Evaluation of Phosphatidylserine-Binding Peptides Targeting Apoptotic Cells

  2012cites this paper
• Radiolabeled Peptides: Valuable Tools for the Detection and Treatment of Cancer

  2012influential citation
• Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT

  2011cites this paper
• Experimental study of 99 mTc-depreotide preparation and its affinity with A 549 cell

  2011cites this paper
• A single replacement of histidine to arginine in EGFR-lytic hybrid peptide demonstrates the improved anticancer activity.

  2011cites this paper
• The synthesis and application of polyamino polycarboxylic bifunctional chelating agents.

  2011cites this paper
• Screening and identification of a renal carcinoma specific peptide from a phage display peptide library

  2011cites this paper
• Fluorous-Phase Purification of ⁹⁹ᵐTc Radiopharmaceuticals

  2010cites this paper
• Synthesis of functionalised HP-DO3A chelating agents for conjugation to biomolecules.

  2009cites this paper
• Oligo-branched peptides for tumor targeting: from magic bullets to magic forks

  2009cites this paper
• Receptor-mediated tumor targeting with radiopeptides

  2009cites this paper
• Synthesis and Biological Evaluation of a Novel Pentagastrin-Toxin Conjugate Designed for a Targeted Prodrug Mono-therapy of Cancer

  2008cites this paper
• Peptide-based radiopharmaceuticals and cytotoxic conjugates: potential tools against cancer.

  2008cites this paper
• Asymmetric Synthesis and Biological Evaluation of Glycosidic Prodrugs for a Selective Cancer Therapy

  2008cites this paper
• Multifunctional Nanotherapeutics for Cancer

  2008cites this paper
• Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides.

  2008cites this paper
• Identification and characterization of a novel peptide ligand of Tie2 for targeting gene therapy.

  2008cites this paper
• Calcitonin-derived peptide carriers: mechanisms and application.

  2008cites this paper
• Synthesis and biological activity of stable branched neurotensin peptides for tumor targeting

  2007cites this paper
• Technetium in Medicine

  2007cites this paper
• Radiolanthanides / Tetraazamacrocycles / Phosphonates / Carboxylates / Biodistribution / Therapy

  2007cites this paper
• Somatostatin with 99mTc and Biodistribution Studies in Rats

  2007cites this paper
• Biological evaluation of 153Sm and 166Ho complexes with tetraazamacrocycles containing methylcarboxylate and/or methylphosphonate pendant arms

  2007cites this paper
• Identification of neuropeptide Y cleavage products in human blood to improve metabolic stability.

  2007cites this paper
• Design, synthesis, and biological evaluation of novel pyridine acid esters of podophyllotoxin and esters of 4′-demethylepipodophyllotoxin

  2007cites this paper
• Identification of a Met-Binding Peptide from a Phage Display Library

  2007cites this paper
• Identification of aMet-Binding Peptide from a Phage Display Library

  2007cites this paper
• Antitumor agents: development of highly potent glycosidic duocarmycin analogues for selective cancer therapy.

  2006cites this paper
• Antitumor‐Wirkstoffe: Entwicklung hochpotenter glycosidischer Duocarmycin‐Analoga für eine selektive Krebstherapie

  2006cites this paper
• Issues related to targeted delivery of proteins and peptides

  2006cites this paper
• DNA-intercalators — the anthracyclines

  2006cites this paper
• In Vitro and in Vivo Antitumor Effects of Cytotoxic Camptothecin-Bombesin Conjugates Are Mediated by Specific Interaction with Cellular Bombesin Receptors

  2006influential citation
• Spectral Polarization Imaging of Human Prostate Cancer Tissue Using a Near-infrared Receptor-targeted Contrast Agent

  2005cites this paper
• Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics

  2005cites this paper
• Solid-phase synthesis of DOTA-peptides.

  2004cites this paper
• A novel small peptide as a targeting ligand for receptor tyrosine kinase Tie2.

  2004cites this paper
• Small molecule toxins targeting tumor receptors.

  2004cites this paper
• Receptor-Mediated Tumor Targeting with Radiopeptides. Part 1. General Concepts and Methods: Applications to Somatostatin Receptor-Expressing Tumors

  2004cites this paper
• Development of High Affinity Camptothecin-Bombesin Conjugates That Have Targeted Cytotoxicity for Bombesin Receptor-containing Tumor Cells*

  2004cites this paper
• Novel modified and radiolabelled neuropeptide Y analogues to study Y-receptor subtypes.

  2004cites this paper
• Improved chemical strategies for the targeted therapy of cancer.

  2003cites this paper
• Synthesis of target-specific radiolabeled peptides for diagnostic imaging.

  2003cites this paper
• 99mTc-labeled neuropeptide Y analogues as potential tumor imaging agents.

  2001cites this paper
• Biophysical methods to study ligand-receptor interactions of neuropeptide Y.

  2001cites this paper